Cited by 29Dermatologic Treatments and Researchmelanin and skin pigmentationSkin Protection and Aging

Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma

Gold, Michael H, Biron, Julie·2011·Journal of Cosmetic Dermatology

Abstract

BACKGROUND: For treating irregular skin pigmentation, a hallmark of premature skin aging, safe and effective alternatives to hydroquinone and kojic acid are being researched. AIMS: Four skin-brightening actives targeting melanin formation at multiple levels, namely disodium glycerophosphate, L-leucine, phenylethyl resorcinol, and undecylenoyl phenylalanine, in an oil-in-water emulsion cream were evaluated. PATIENTS/METHODS: Twenty female patients with mild-to-moderate epidermal melasma were included. After a washout period of 1 month with a sunscreen, they continued using the sunscreen and added the novel skin-brightening cream for 12 weeks twice daily to entire face. RESULTS: Whereas there was no significant change in skin pigmentation during the washout, signs for uneven skin tone including melasma area and severity and appearance of lentigines significantly decreased by up to 43% after the 12-week treatment period with the skin-brightening cream. The skin-brightening complex is well tolerated, which should allow its continued use over a prolonged period of time, in particular, when comparing skin-brightening approaches with exfoliating or peeling agents. CONCLUSIONS: When used with a daily sunscreen, the skin-brightening complex represents a valuable alternative to hydroquinone products and can be used for maintenance or adjunct skin care with lightening therapies.

Integrity signals

Registry

Crossref · 10.1111/j.1473-2165.2011.00573.x

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Gold and Biron's study has small sample size and no control group, making level of evidence low.

    “The sample size is relatively small, which may limit the generalizability of the findings. In addition, there was no control group in the study, making it difficult to determine if the observed improvements were due to the treatment or other factors.”

    From Cosmeceuticals in photoaging: A review. (2024) · cites this paper as [66]

  • Gold and Biron reported significant improvement in melasma severity and pigmentation after treatment with a hydroquinone-free skin-brightening cream.

    “The authors reported a significant improvement in melasma severity and pigmentation after treatment with the cream.”

    From Cosmeceuticals in photoaging: A review. (2024) · cites this paper as [66]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

  • Cosmeceuticals in photoaging: A review.

    Chan, L. K. W., Lee, K. W. A., Lee, C. H., Lam, K. W. P., Lee, K. F. V., Wu, R., Wan, J., Shivananjappa, S., Sky, W. T. H., Choi, H., et al. (2024) · Skin Research and Technology · doi:10.1111/srt.13730 · Cited by 23 · see citing works

    “Overall, the study by Gold and Biron 66 provides preliminary evi-denceontheefficacyofthehydroquinone-freeskin-brighteningcream in patients with melasma.”
    BackgroundResult

Authors
Gold, M. H., & Biron, J.
Affiliations
  • Gold Skin Care Center (US)
  • Tennessee Clinical Research Center (US)
Venue
Journal of Cosmetic Dermatology
Publisher
Wiley
Published
2011-09
Volume
10
Issue
3
Pages
189-196
ISSN
1473-2130 (ISSN-L)
OpenAlex
W1936785858
Cited by
29
References
19
Citations by year
2026: 2 · 2025: 4 · 2024: 1 · 2023: 2 · 2022: 2 · 2020: 4 · 2019: 2 · 2017: 2 · 2016: 2 · 2014: 2 · 2013: 4 · 2012: 2
FWCI
3.41
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Cosmetic Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
Keywords
melasma, leucine, melanogenesis, skin pigmentation, lentigines, sunscreen, skin care, premature skin aging
MeSH terms
Adult, Benzhydryl Compounds, Dermatologic Agents, Drug Combinations, Female, Glycerophosphates, Humans, Leucine, Melanosis, Middle Aged, Melanocyte-Stimulating Hormones, Phenylalanine, Resorcinols, Severity of Illness Index, Treatment Outcome, Lipopeptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review